3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
2
Fatty Liver
2
Diabetes Mellitus
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Obesity
1
Neoplasms
1
Lymphoma
1
Iron Overload
1
Hemoglobinopathies
1
Glucose Metabolism Disorders
1
Glucose Intolerance
1
Fibrous Dysplasia, Polyostotic
1
Fibrous Dysplasia of Bone
1
Interventions
Blood Specimen Collection
5
Surveys and Questionnaires
3
exemestane
2
Tirzepatide
2
Tamoxifen
2
Observation
2
Esophagectomy
2
Biopsy
2
BaseLine dental cement
2
Bariatric Surgery
2
Anastrozole
2
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Utrogestan
1
Urine Specimen Collection
1
Topiramate
1
Testosterone
1
Stents
1
Qsymia
1
Phentermine
1
Naltrexone
1
Metabolic Networks and Pathways
1
Medical History Taking
1
Mammography
1
Liraglutide
1
Letrozole
1
Hematologic Tests
1
Gonadotropin-Releasing Hormone
1
Glucose Tolerance Test
1
Glucagon-Like Peptide-1 Receptor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Obesity
×
Glucose Tolerance Test
×
Clear all
NCT03041129
2024-04-17
PLUM
University of Colorado, Denver
Completed
19 enrolled
10 charts